Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study
- 6 January 2010
- journal article
- Published by Springer Science and Business Media LLC in Archiv für die gesamte Virusforschung
- Vol. 155 (3), 329-334
- https://doi.org/10.1007/s00705-009-0583-6
Abstract
We performed a pilot surveillance study on transmitted HIV drug resistance (TDR) in Iran, with specimens collected and stored as dried blood spots (DBS). The protease region and relevant positions in the reverse transcriptase region of the pol gene were sequenced to detect mutations known to be associated with resistance to drugs in standard first-line regimens. Seventy-three specimens were collected, with 39 (53%) specimens yielding sequence from both protease and at least part of RT. Specimens were almost exclusively HIV-1 subtype CRF 35_A1D based on pol sequencing. Mutations were restricted to RT, with D67DG and V75AV each seen in a single specimen. An atypical protease inhibitor mutation, I47M, appeared at a resistance-associated position in protease from a single specimen. These preliminary data showed that the rate of transmitted drug resistance in Iran, within the areas sampled, was 5.1% (2/39). However, the small sample size makes this figure only an approximation. Due to the sampling strategy and resulting small sample size, we were unable to accurately calculate TDR rates for individual areas using the WHO HIV drug resistance threshold survey method. Increasing the sample size and improving the yield from DBS would improve the accuracy of drug resistance surveillance and facilitate wider application of this methodology in Iran.Keywords
This publication has 17 references indexed in Scilit:
- Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistanceJournal of Antimicrobial Chemotherapy, 2008
- Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in AngolaJournal of Antimicrobial Chemotherapy, 2008
- HIV Type 1 Subtype A Epidemic in Injecting Drug User (IDU) Communities in IranAIDS Research and Human Retroviruses, 2007
- A Nascent HIV Type 1 Epidemic among Injecting Drug Users in Kabul, Afghanistan Is Dominated by Complex AD Recombinant Strain, CRF35_ADAIDS Research and Human Retroviruses, 2007
- Evaluation of Dried Blood Spots for Human Immunodeficiency Virus Type 1 Drug Resistance TestingJournal of Clinical Microbiology, 2007
- Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-IranInfectious Agents and Cancer, 2006
- High Prevalence of HIV Infection Associated With Incarceration Among Community-Based Injecting Drug Users in Tehran, IranJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Among 46 Near Full Length HIV Type 1 Genome Sequences from Rakai District, Uganda, Subtype D and AD Recombinants PredominateAIDS Research and Human Retroviruses, 2002
- High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'IvoireJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequencesJournal of Molecular Evolution, 1980